| 1 |
34929577 | Mesalazine initiates an anti-oncogenic β-catenin / MUCDHL negative feed-back loop in colon cancer cells by cell-specific mechanisms. | 2022 Feb |
2 |
| 2 |
33785874 | 5-Aminosalicylic acid inhibits stem cell function in human adenoma-derived cells: implications for chemoprophylaxis in colorectal tumorigenesis. | 2021 Jun |
1 |
| 3 |
27310872 | Expression of μ-protocadherin is negatively regulated by the activation of the β-catenin signaling pathway in normal and cancer colorectal enterocytes. | 2016 Jun 16 |
1 |
| 4 |
25569743 | Overexpression of PAK1 promotes cell survival in inflammatory bowel diseases and colitis-associated cancer. | 2015 Feb |
1 |
| 5 |
23146664 | Mesalamine modulates intercellular adhesion through inhibition of p-21 activated kinase-1. | 2013 Jan 15 |
2 |
| 6 |
23867870 | Antioxidant properties of mesalamine in colitis inhibit phosphoinositide 3-kinase signaling in progenitor cells. | 2013 Sep |
3 |
| 7 |
24030235 | 5-Aminosalicylic acid and chemoprevention: does it work? | 2013 |
1 |
| 8 |
22198215 | The influence of 5-aminosalicylic acid on the progression of colorectal adenomas via the β-catenin signaling pathway. | 2012 Mar |
1 |
| 9 |
21315419 | Down-regulation of μ-protocadherin expression is a common event in colorectal carcinogenesis. | 2011 Jul |
1 |
| 10 |
19879273 | Mesalamine inhibits epithelial beta-catenin activation in chronic ulcerative colitis. | 2010 Feb |
9 |
| 11 |
16728434 | Protein phosphatase 2A is required for mesalazine-dependent inhibition of Wnt/beta-catenin pathway activity. | 2006 Dec |
10 |